Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populations

Brazilian Journal of Infectious Diseases

Volumn 18, Issue 2, 2014, Pages 170-176

  Machado, Silmara Rodrigues ^a,b   Parise, Edison Roberto ^a   de Carvalho, Luciana ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

Caffeine; Coffee; Fibrosis; Hepatitis C

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CAFFEINE; GAMMA GLUTAMYLTRANSFERASE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BRAZIL; COFFEE; ECHOGRAPHY; ENDOSCOPY; ENZYME BLOOD LEVEL; EUROPE; FEMALE; FOOD INTAKE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER PROTECTION; MAJOR CLINICAL STUDY; MALE; STRUCTURED QUESTIONNAIRE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMERICAN; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAZILIAN; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; EUROPEAN; EVALUATION STUDY; FATTY LIVER; FOOD FREQUENCY QUESTIONNAIRE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN TISSUE; LIVER FIBROSIS; METABOLIC RATE; MIDDLE AGED;

CAFFEINE; COFFEE; FIBROSIS; HEPATITIS C;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BRAZIL; CAFFEINE; COFFEE; EUROPE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; TRANSAMINASES; UNITED STATES;

EID: 84897618433     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2013.09.001     Document Type: Article

References (49)

1. Alter M.J. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007, 13:2436-2441.
2. Martins A.N., Arruda M.B., Aleixo A.W., et al. Prevalence of etravirine-associated mutations in clinical samples with genotypic resistance to nevirapine and efavirenz in Brazilian clinics. J Acquir Immune Defic Syndr 2011, 57:193-196.
3. Feng R., Lu Y., Bowman L.L., Qian Y., Castranova V., Ding M. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 2005, 280:27888-27895.
4. Gomez-Ruiz J.A., Leake D.S., Ames J.M. In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem 2007, 55:6962-6969.
5. Higdon J.V., Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006, 46:101-123.
6. Cavin C., Holzhauser D., Constable A., Huggett A.C., Schilter B. The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism. Carcinogenesis 1998, 19:1369-1375.
7. Ikeda M., Maki T., Yin G., et al. Relation of coffee consumption and serum liver enzymes in Japanese men and women with reference to effect modification of alcohol use and body mass index. Scand J Clin Lab Invest 2010, 70:171-179.
8. Ruhl C.E., Everhart J.E. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005, 128:24-32.
9. Tanaka K., Tokunaga S., Kono S., et al. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998, 27:438-443.
10. Corrao G., Lepore A.R., Torchio P., et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study, Provincial Group for the Study of Chronic Liver Disease. Eur J Epidemiol 1994, 10:657-664.
11. Corrao G., Zambon A., Bagnardi V., D'Amicis A., Klatsky A. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol 2001, 11:458-465.
12. Gallus S., Tavani A., Negri E., La Vecchia C. Does coffee protect against liver cirrhosis?. Ann Epidemiol 2002, 12:202-205.
13. Hu G., Tuomilehto J., Pukkala E., et al. Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology 2008, 48:129-136.
14. Inoue M., Yoshimi I., Sobue T., Tsugane S. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005, 97:293-300.
15. Shimazu T., Tsubono Y., Kuriyama S., et al. Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 2005, 116:150-154.
16. Gelatti U., Covolo L., Franceschini M., et al. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol 2005, 42:528-534.
17. Montella M., Polesel J., La Vecchia C., et al. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer 2007, 120:1555-1559.
18. Tanaka K., Hara M., Sakamoto T., et al. Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan. Cancer Sci 2007, 98:214-218.
19. Bravi F., Bosetti C., Tavani A., et al. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 2007, 46:430-435.
20. Larsson S.C., Wolk A. Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology 2007, 132:1740-1745.
21. Costentin C.E., Roudot-Thoraval F., Zafrani E.S., et al. Association of caffeine intake and histological features of chronic hepatitis C. J Hepatol 2011, 54:1123-1129.
22. Modi A.A., Feld J.J., Park Y., et al. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 2010, 51:201-209.
23. Gutierrez-Grobe Y., Chavez-Tapia N., Sanchez-Valle V., et al. High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity. Ann Hepatol 2012, 11:350-355.
24. Molloy J.W., Calcagno C.J., Williams C.D., Jones F.J., Torres D.M., Harrison S.A. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 2012, 55:429-436.
25. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
26. Gayotto L.C.C. Comitê SBP/SBH. Visão histórica e consenso nacional sobre a classificação das hepatites crÔnicas. Projeto do Clube de Patologia Hepática da Sociedade Brasileira de Patologia aprovado pela Sociedade Brasileira de Hepatologia. GED Gastroenterol Endosc Dig 2000, 19:137-140.
27. Health Professionals Follow-up Study Questionnaire. ; 1998. http://www.hsph.harvard.edu/hpfs/hpfs.
28. McCusker R.R., Goldberger B.A., Cone E.J. Caffeine content of specialty coffees. J Anal Toxicol 2003, 27:520-522.
29. Michels K.B., Willett W.C., Fuchs C.S., Giovannucci E. Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J Natl Cancer Inst 2005, 97:282-292.
30. Iso H., Date C., Wakai K., Fukui M., Tamakoshi A. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 2006, 144:554-562.
31. Shimbo M., Nakamura K., Jing Shi H., et al. Green tea consumption in everyday life and mental health. Public Health Nutr 2005, 8:1300-1306.
32. Freedman N.D., Everhart J.E., Lindsay K.L., et al. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 2009, 50:1360-1369.
33. Honjo S., Kono S., Coleman M.P., et al. Coffee drinking and serum gamma-glutamyltransferase: an extended study of Self-Defense Officials of Japan. Ann Epidemiol 1999, 9:325-331.
34. Freedman N.D., Curto T.M., Lindsay K.L., Wright E.C., Sinha R., Everhart J.E. Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C. Gastroenterology 2011, 140:1961-1969.
35. Willett W. Nutritional epidemiology 1998, Oxford University Press, New York. 2nd ed.
36. Casiglia E., Spolaore P., Ginocchio G., Ambrosio G.B. Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol 1993, 9:293-297.
37. Chan E.S., Montesinos M.C., Fernandez P., et al. Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol 2006, 148:1144-1155.
38. Hashmi A.Z., Hakim W., Kruglov E.A., et al. Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2007, 292:G395-G401.
39. Sohail M.A., Hashmi A.Z., Hakim W., et al. Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition. Hepatology 2009, 49:185-194.
40. Che J., Chan E.S., Cronstein B.N. Adenosine A2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway. Mol Pharmacol 2007, 72:1626-1636.
41. Peng Z., Fernandez P., Wilder T., et al. Ecto-5'-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis. FASEB J 2008, 22:2263-2272.
42. Tofovic S.P., Salah E.M., Jackson E.K., Melhem M. Early renal injury induced by caffeine consumption in obese, diabetic ZSF1 rats. Renal Failure 2007, 29:891-902.
43. Lee C. Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation. Clin Chim Acta 2000, 295:141-154.
44. Ozercan I.H., Dagli A.F., Ustundag B., et al. Does instant coffee prevent acute liver injury induced by carbon tetrachloride (CCl(4))?. Hepatol Res 2006, 35:163-168.
45. Scharf G., Prustomersky S., Huber W.W. Elevation of glutathione levels by coffee components and its potential mechanisms. Adv Exp Med Biol 2001, 500:535-539.
46. Cavin C., Marin-Kuan M., Langouet S., et al. Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver. Food Chem Toxicol 2008, 46:1239-1248.
47. Higgins L.G., Cavin C., Itoh K., Yamamoto M., Hayes J.D. Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein. Toxicol Appl Pharmacol 2008, 226:328-337.
48. Lee J.H., Sul D., Oh E., et al. Panax ginseng effects on DNA damage, CYP1A1 expression and histopathological changes in testes of rats exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Food Chem Toxicol 2007, 45:2237-2244.
49. Gressner O.A., Lahme B., Rehbein K., Siluschek M., Weiskirchen R., Gressner A.M. Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol 2008, 49:758-767.